Phase 1 Single Ascending Doses (SAD) of M5542 in Healthy Participants
NCT06577337
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
49
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
BIOLOGICAL:
M5542
BIOLOGICAL:
Placebo
Sponsor
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany